THE NORTH SUBURBAN PHARMACISTS of CHICAGOLAND ASSOCIATION
  • Home
  • OPIOID USE DISORDER: FUNDAMENTAL PATHOPHYSIOLOGY AND THERAPEUTIC MANAGEMENT PRINCIPLES. Program 193

OPIOID USE DISORDER: FUNDAMENTAL PATHOPHYSIOLOGY AND THERAPEUTIC MANAGEMENT PRINCIPLES. Program 193

  • 01/11/2022
  • 7:00 PM - 8:30 PM
  • Virtual Program

Registration

The North Suburban Pharmacists of Chicagoland Presents

OPIOID USE DISORDER: FUNDAMENTAL PATHOPHYSIOLOGY AND THERAPEUTIC MANAGEMENT PRINCIPLES. Program 193

SECOND NOTICE: This program is intended for NSP members, IPhA members, and those who want to join and support our associations in their important pharmacy related functions. Disregard this notice if you have already registered.

All College of Pharmacy students are welcome to attend. Please use your personal email to register (not your university email).

Tuesday, January 11, 2022.
Time: 7pm to 8:30pm
Location: Virtual Program

Register in advance for this meeting:

https://ipha.memberclicks.net/NSP-Jan-2022

 

After registering, you will receive a confirmation email containing information about joining the meeting.

Schedule of Events:
7:00 p.m.-8:30 p.m.: Featured CE Program Presentation.

Reservations are required for attendance.

OPIOID USE DISORDER: FUNDAMENTAL PATHOPHYSIOLOGY AND THERAPEUTIC MANAGEMENT PRINCIPLES. Program 193

The North Suburban Pharmacists of Chicagoland is providing our virtual continuing pharmacy education program experience. NSP is committed to providing thoughtful and engaging programs. Your support of ALL pharmacy organizations (ex. IPhA, NSP, APhA, etc.) is more important now than ever. NSP is hopeful that you will participate and grow your knowledge with us.

www.nspharmacists.org

www.ipha.org

Program Introduction

Opioid Use Disorder

Persistent use of opioids despite the adverse consequences of its use

Association: Physical, mental, social and legal problems

Chronic Disease

  • o   However, it can respond to treatment
  • o   Correct medications
  • o   Improves outcomes
  • o   Facilitates recovery
  • o   Protects against overdose

Many clinicians and the lay public do not believe that OUD is a chronic disease

Participant Program Objectives

At the conclusion of the program, the pharmacists and techs will be able to:

 

Pharmacists

1. List FDA approved medications for the treatment opioid use disorder.

2. Explain pharmacokinetic principles of FDA-approved medications for Opioid Use Disorder treatment.

3. Describe how pharmacokinetic principles are applied to prevent buprenorphine diversion.

Pharmacy Technicians

1. List 3 risk factors for developing opioid use disorder.

2. Identify three stages of opioid use disorder.

3. Explain the trend in opioid overdose death rate during the COVID-19 pandemic.

 

TARGET AUDIENCE

This activity has been designed to meet the educational needs of pharmacists and pharmacy technicians.

SPEAKER

Ajna Hamidovic, PharmD, MS

Assistant Professor University of Illinois College of Pharmacy

Department of Pharmacy Practice. Chicago, IL

 

Disclosure: Our speaker declares no conflicts of interest, real or apparent, and no financial interests in any company, product, or service mentioned in this program.

In compliance with regulatory and continuing education guidelines/codes of ethics, guests who are not healthcare professionals are not permitted to attend.

CONTINUING EDUCATION CREDIT INFORMATION: The Illinois Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmaceutical education.

Funding for this program is provided by: North Suburban Pharmacists of Chicagoland 

In order to receive ACPE credit for this program, the participant must 1) Attend the program in its entirety; 2) Provide current information on the Attendance Log Form; and 3) Complete an Evaluation Form. The program’s administrator should provide attendees a Record of Attendance Form for their files. All Statements of Credit for ACPE approved – IPhA co-sponsored continuing education that individuals have completed during the year are available online at www.ipha.org.  If you do not have web access and would like a CE transcript mailed to you, please contact IPhA at (217) 522-7300 or ipha@ipha.org.

There are no fees for this program.

Register in advance for this meeting:

https://ipha.memberclicks.net/NSP-Jan-2022

Tuesday, January 11, 2022.
Time: 7pm to 8:30pm
Location: Virtual Program

After registering, you will receive a confirmation email containing information about joining the meeting.

 

©2021 North Suburban Pharmacists of Chicagoland Association. All Rights Reserved

Powered by Wild Apricot Membership Software